USDA Retracts 2020 Rules on Genetically Modified Organisms In a surprising move, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) revealed
Category: Biotechnology
Innovation in Biotechnology: Iran and Tajikistan Strengthen Ties
Tehran’s strategic partnership with Tajikistan in the realm of biotechnology is set to flourish. Officials from both countries recently convened in Tajikistan to discuss enhanced
Leadership Shake-up: What’s Next for Lixte Biotechnology?
With a notable departure shaking the foundations at Lixte Biotechnology, many are left wondering about the future. Former CEO Forman has officially exited the company,
Unlocking the Future of Medicine! Discover the Secrets of Red Biotechnology
The Expanding Red Biotechnology Market The Red Biotechnology Market is gaining significant traction, projected to achieve a remarkable compound annual growth rate (CAGR) of 5.2%
Big Win for U.S. Corn! Mexico’s Ban on Biotech Corn Challenged
United States Triumphs in Key Agricultural Dispute In a significant ruling, the United States has secured a victory under the United States-Mexico-Canada Agreement (USMCA) regarding
Record Growth: This Year’s Biotech Stocks Shock the Market! Don’t Miss Out
Biopharma stocks had a mixed bag in 2024, showing some surprising shifts amidst challenges. The iShares Biotechnology ETF, renowned as the largest of its kind,
Investors’ Eyes Are on Altimmune! Groundbreaking Treatments on the Horizon
Unlocking the Future of Biotechnology The Nasdaq Biotechnology Index serves as a key gauge of biotechnology and pharmaceutical firms, highlighting their performance based on market
Investors Shift Focus: State Street Boosts Stake in Vir Biotechnology
State Street Corp has recently increased its investment in Vir Biotechnology, Inc. According to the latest 13F filing with the Securities & Exchange Commission, the
Major Shake-Up for Vir Biotechnology! What Investors Need to Know
Y Intercept Hong Kong Reduces Holdings Significantly In a surprising turn of events, Y Intercept Hong Kong Ltd dramatically cut its stake in Vir Biotechnology,
Groundbreaking News in Biotech! Oruka Therapeutics Joins the Nasdaq Biotechnology Index
Oruka Therapeutics, a leading biotechnology firm specializing in innovative biologics for chronic skin disease treatment, is set to make waves by joining the esteemed Nasdaq